On April 4, 2022 Janet Church, Sjögren’s Foundation CEO, and Cassandra Calabrese, DO, member of the Foundation’s COVID-19 Vaccination Committee, discussed the current recommendations for the “second booster” of the vaccine. In this video they discuss evolving COVID-19 precautions, the fourth dose vaccine recommendation, and other topics that could impact you as a Sjögren’s patient.

Learn more about:
• Vaccine & booster risk/benefit recommendations
• New medication options for Sjögren’s patients on immunosuppressive drugs such as rituximab
• Emergency use authorization (EUA) of EVUSHELDTM (tixagevimab co-packaged with cilgavimab): [ Ссылка ]
• The new COVID-19 Omicron variant BA.2
• Suggestions about social distancing and masking

свернуть